Such EV analysis in human patients identified the potential of CD14+ EVs, derived from monocytes and macrophages, and Vα21/Vβ11+ EVs, derived from invariant NK T (iNKT)-cells, to diagnose patients with NAFLD from healthy individuals. This evidence concerns the gene CD14 and metabolic dysfunction-associated steatotic liver disease.